, Volume 20, Issue 8, pp 1214-1220
Date: 03 Jul 2006

Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS)

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Background

The Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS) was developed to provide at the national level an informative tool useful for performing multicenter studies in the field of spleen laparoscopic surgery. In this first study analyzing the IRLSS data, a cohort of patients with hematologic diseases was retrospectively investigated for potential predictive parameters that could affect the outcome of laparoscopic splenectomy.

Methods

A total of 309 patients who underwent laparoscopic splenectomy for hematologic diseases in 17 Italian centers (between February 1, 1993, and September 30, 2004) were entered in the IRLSS. Their records were analyzed retrospectively by the Student’s t-test, chi-square, and logistic regression.

Results

The mean operative time was 141 min (range, 30–420 min). Conversion was necessary in 21 cases (7%), and approximately 1 accessory spleen in 25 patients (9%) was found. The mean spleen weight was 1191 g (range, 85–4,500 g). Perioperative death occurred in two cases (0.6%). No complications were experienced by 253 patients (81.9%), who had a mean hospital stay of 5.4 days (range, 2–30 days). Overall morbidity occurred in 56 patients (18.1%), mainly associated with transient fever (n = 22), pleural effusion (n = 13), and actual or suspected hemorrhage (n = 12), requiring a reintervention for 7 patients. Multivariate analysis found that body mass index (p = 0.024) and clinical indication (p = 0.004) were independent predictors for surgical conversion. The clinical indication was almost significant as an independent predictor for the occurrence of postoperative complication (p = 0.05).

Conclusions

This first study analyzing the IRLSS data shows that laparoscopic splenectomy may represent the gold standard treatment for hematologic diseases with normal-size spleen. The low morbidity and mortality rate suggests that laparoscopic splenectomy can be successfully proposed also for splenomegaly in hematologic malignancies.

IRLSS Centers: SS Antonio e Biagio Hospital, Alessandria (Dr. G. Spinoglio); F. Miulli Regional Hospital, Acquaviva delle Fonti (Dr. G. Logrieco); Bufalini Hospital, Cesena (Dr. F. Buccoliero); Careggi Hospital, Florence (Dr. A. Valeri); Cisanello Hospital, Pisa (Dr. A. Pietrabissa); Arcispedale S. Maria Nuova, Reggio Emilia (Dr. C. Pedrazzoli); San Gerardo Hospital, Monza (Dr. F. Uggeri); University Hospital, Modena (Prof. M. Saviano); Policlinic University Hospital, Udine (Prof. F. Bresadola); Humanitas Clinical Institute, Rozzano (Dr. R. Rosati); S. Anna Hospital, Ferrara (Dr. I. Donini); San Giacomo Hospital, Rome (Dr. A. Moraldi); San Martino University Hospital, Genoa (Dr. P. Torelli); San Paolo Hospital, Savona (Prof. P. Cavaliere); Santo Spirito Hospital, Pescara (Dr. G. Colecchia); Umberto I Hospital, Rome (Prof. N. Basso); Policlinic University Hospital, Bari (Prof. F. Prete)